日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessing the Malaysian Regulatory Process for Medicinal Product Approval: An OpERA Methodology and Standardized Reporting Approach

评估马来西亚药品审批监管流程:OpERA 方法论和标准化报告方法

Mohd Sani, Noraisyah; Kasbon, Siti Hidayah; Yap, Kian Yee; Abdullah, Muhamad Firdaus; Lajis, Rosliza; Ramli, Azuana; McAuslane, Neil; Bujar, Magda; Kermad, Adem

Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study

马来西亚接种BNT162b2、CoronaVac和ChAdOx1疫苗后发生严重不良事件的风险:一项自身对照病例系列研究

Ab Rahman, Norazida; Lim, Ming Tsuey; Lee, Fei Yee; Lee, Sing Chet; Ramli, Azuana; Saharudin, Siti Nurhafizah; King, Teck Long; Anak Jam, Emelyne Bani; Ayub, Nor Aliya; Sevalingam, Raj Kumar; Bahari, Rashidah; Ibrahim, Nor Nadziroh; Mahmud, Fatihah; Sivasampu, Sheamini; Peariasamy, Kalaiarasu M

National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool

使用多属性评分工具对国家药物处方集他汀类药物治疗组进行审查

Ramli, Azuana; Aljunid, Syed Mohamed; Sulong, Saperi; Md Yusof, Faridah Aryani